Skip Navigation LinksHome > September 2013 - Volume 19 - Issue 10 > Increased Prevalence of Luminal Narrowing and Stricturing Id...
Inflammatory Bowel Diseases:
doi: 10.1097/MIB.0b013e31829706e0
Original Clinical Articles

Increased Prevalence of Luminal Narrowing and Stricturing Identified by Enterography in Pediatric Crohn’s Disease Patients With Elevated Granulocyte–Macrophage Colony Stimulating Factor Autoantibodies

Dykes, Dana M. H. MD*; Towbin, Alexander J. MD; Bonkowski, Erin*; Chalk, Claudia; Bezold, Ramona RN, BSN*; Lake, Kathleen MSW*; Kim, Mi-Ok PhD§,‖; Heubi, James E. MD*; Trapnell, Bruce C. MD; Podberesky, Daniel J. MD; Denson, Lee A. MD*

Supplemental Author Material
Collapse Box

Abstract

Background: Crohn’s disease (CD) patients with elevated granulocyte–macrophage colony-stimulating factor autoantibodies (GM-CSF Ab) are more likely to develop stricturing behavior requiring surgery. Computed tomography or magnetic resonance enterography (CTE or MRE) may detect luminal narrowing (LN) before stricture development. The objective of this study was to determine whether CD patients with elevated GM-CSF Ab (≥1.6 μg/mL) have a higher prevalence of LN and stricturing on CTE or MRE.

Methods: A single-center, cross-sectional study of 153 pediatric patients with CD and control subjects undergoing diagnostic CTE or MRE. Examinations were evaluated for disease activity using a novel scoring system and for the presence of LN, stricture, intra-abdominal abscess, or fistulae. Dichotomous outcomes were compared with respect to antibody status (high or low) using Fisher’s exact test and logistic regression, whereas continuous outcomes were evaluated using unpaired t test.

Results: GM-CSF Ab were elevated in CD patients (n = 114) with a median (interquartile range) GM-CSF Ab level of 2.3 μg/mL (0.5–6.6 μg/mL) compared with 0.6 μg/mL (0.3–1.3 μg/mL) in healthy and disease control subjects (n = 39) (P = 0.001). Ileal disease location was more common in CD patients with high GM-CSF Ab (P < 0.001). LN increased from 39% in CD patients with low GM-CSF Ab to 71% in those with high levels (P = 0.004) and remained significantly associated with high GM-CSF Ab in a multivariate logistic model, which included age, gender, small bowel location, and duration of disease. Stricturing prevalence on CTE or MRE examination increased from 4% in CD patients with low GM-CSF Ab to 19% in those with high GM-CSF Ab (P = 0.03).

Conclusions: Pediatric CD patients with high GM-CSF Ab levels have a higher prevalence of LN on CTE or MRE. Further study will be needed to determine whether medical therapy will reduce progression to stricturing behavior in these patients.

© Crohn's & Colitis Foundation of America, Inc.

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.